|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM244605432 |
003 |
DE-627 |
005 |
20231224135048.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2015 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2014.12.003
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0815.xml
|
035 |
|
|
|a (DE-627)NLM244605432
|
035 |
|
|
|a (NLM)25510482
|
035 |
|
|
|a (PII)S1521-6616(14)00270-8
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Rahman, Sayma
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells
|
264 |
|
1 |
|c 2015
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 30.04.2015
|
500 |
|
|
|a Date Revised 07.12.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2014. Published by Elsevier Inc.
|
520 |
|
|
|a Control of human tuberculosis (TB) requires induction and maintenance of both macrophage and T cell effector functions. We demonstrate that pulmonary TB patients with a vitamin D deficiency had significantly reduced local levels of the vitamin D-inducible antimicrobial peptide LL-37 in granulomatous lesions compared to distal parenchyma from the infected lung. Instead, TB lesions were abundant in CD3(+) T cells and FoxP3(+) regulatory T cells as well as IgG-secreting CD20(+) B cells, particularly in sputum-smear positive patients with cavitary TB. Mycobacteria-specific serum IgG titers were also elevated in patients with active TB. An up-regulation of the B cell stimulatory cytokine IL-21 correlated with mRNA expression of CD20, total IgG and also IL-10 in the TB lesions. Altogether, vitamin D-deficient TB patients expressed a weak antimicrobial response but an IL-21 associated expansion of IgG-secreting B cells combined with a rise in FoxP3(+) regulatory T cells at the local site of infection
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Antimicrobial peptide
|
650 |
|
4 |
|a B cell
|
650 |
|
4 |
|a Human
|
650 |
|
4 |
|a Lung
|
650 |
|
4 |
|a T cell
|
650 |
|
4 |
|a Tuberculosis
|
650 |
|
7 |
|a Antigens, CD20
|2 NLM
|
650 |
|
7 |
|a Antimicrobial Cationic Peptides
|2 NLM
|
650 |
|
7 |
|a FOXP3 protein, human
|2 NLM
|
650 |
|
7 |
|a Forkhead Transcription Factors
|2 NLM
|
650 |
|
7 |
|a IL10 protein, human
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
650 |
|
7 |
|a Interleukins
|2 NLM
|
650 |
|
7 |
|a Interleukin-10
|2 NLM
|
650 |
|
7 |
|a 130068-27-8
|2 NLM
|
650 |
|
7 |
|a 25-Hydroxyvitamin D 2
|2 NLM
|
650 |
|
7 |
|a 21343-40-8
|2 NLM
|
650 |
|
7 |
|a interleukin-21
|2 NLM
|
650 |
|
7 |
|a MKM3CA6LT1
|2 NLM
|
650 |
|
7 |
|a Calcifediol
|2 NLM
|
650 |
|
7 |
|a P6YZ13C99Q
|2 NLM
|
650 |
|
7 |
|a Cathelicidins
|2 NLM
|
700 |
1 |
|
|a Rehn, Anders
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rahman, Jubayer
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Andersson, Jan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Svensson, Mattias
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Brighenti, Susanna
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 156(2015), 2 vom: 02. Feb., Seite 85-97
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:156
|g year:2015
|g number:2
|g day:02
|g month:02
|g pages:85-97
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2014.12.003
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 156
|j 2015
|e 2
|b 02
|c 02
|h 85-97
|